Samenvatting
The ability to control antibody activity by pH has important applications in diagnostics, therapeutic antibody targeting, and antibody-guided imaging. Here, we report the rational design of bivalent peptide-DNA ligands that allow pH-dependent control of antibody activity. Our strategy uses a pH-responsive DNA triple helix to control switching from a tight-binding bivalent peptide-DNA lock into a weaker-binding monovalent ligand. Different designs are introduced that allow antibody activation at both basic and acidic pHs, either autonomously or in the presence of an additional oligonucleotide trigger. The pH of antibody activation could be precisely tuned by changing the DNA triple helix sequence. The peptide-DNA locks allowed pH-dependent antibody targeting of tumor cells both in bulk and for single cells confined in water-in-oil microdroplets. The latter approach enables high-throughput antibody-mediated detection of single tumor cells based on their distinctive metabolic activity.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 22-31 |
Aantal pagina's | 10 |
Tijdschrift | ACS Central Science |
Volume | 6 |
Nummer van het tijdschrift | 1 |
DOI's | |
Status | Gepubliceerd - 22 jan. 2020 |
Financiering
We thank M. Rosmalen and S. Wouters for support with the flow cytometry equipment and titration experiments and N. Sinha for support with the microfluidic setup. We are grateful to F. del Ben for fruitful discussions regarding metabolic profiling of tumor cells in microdroplets. This work was supported by funding from by European Research Council (ERC) Starting Grant (280255) and the Ministry of Education, Culture and Science (Gravity program, 024.001.035).
Financiers | Financiernummer |
---|---|
Horizon 2020 Framework Programme | 280255, 802791 |
European Research Council | |
Ministerie van OCW | 024.001.035 |